| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01:25 | VITURA HEALTH LIMITED: Withdrawal of resolution | 1 | ASX | ||
| 28.10. | VITURA HEALTH LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 27.10. | VITURA HEALTH LIMITED: Resignation of CFO and Company Secretary | 2 | ASX | ||
| 22.10. | VITURA HEALTH LIMITED: Notice of 2025 Annual General Meeting | - | ASX | ||
| VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
| 22.10. | VITURA HEALTH LIMITED: 2025 Annual Report | - | ASX | ||
| 01.10. | VITURA HEALTH LIMITED: Application for quotation of securities - VIT | 1 | ASX | ||
| 25.09. | VITURA HEALTH LIMITED: Update - Dividend/Distribution - VIT | - | ASX | ||
| 25.09. | VITURA HEALTH LIMITED: DRP allocation price | - | ASX | ||
| 24.09. | VITURA HEALTH LIMITED: Date for 2025 AGM | - | ASX | ||
| 09.09. | VITURA HEALTH LIMITED: Becoming a substantial holder | - | ASX | ||
| 09.09. | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX | ||
| 05.09. | Dividendenbekanntmachungen (05.09.2025) | 12.842 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAON INC US0003602069 0,1 USD 0,0858 EUR ACUSHNET HOLDINGS CORP US0050981085 0,235 USD 0,2017 EUR AIA GROUP LTD HK0000069689 0... ► Artikel lesen | |
| 27.08. | VITURA HEALTH LIMITED: Investor Webinar and presentation | - | ASX | ||
| 25.08. | VITURA HEALTH LIMITED: Dividend/Distribution - VIT | - | ASX | ||
| 25.08. | VITURA HEALTH LIMITED: Declaration of dividend | - | ASX | ||
| 25.08. | VITURA HEALTH LIMITED: FY2025 Financial Results | - | ASX | ||
| 25.08. | VITURA HEALTH LIMITED: ASX Appendix 4G Corporate Governance Principles | - | ASX | ||
| 25.08. | VITURA HEALTH LIMITED: 2025 Financial Report | - | ASX | ||
| 25.08. | VITURA HEALTH LIMITED: ASX Appendix 4E Preliminary Final Report | - | ASX | ||
| 04.08. | VITURA HEALTH LIMITED: Notification regarding unquoted securities - VIT | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,760 | -1,05 % | Aurora Cannabis Inc.: Aurora Cannabis Announces Fiscal 2026 Second Quarter Results | Expands YoY Global Medical Cannabis Net Revenue 1 by 15% to Record $70.5 million
Increases International Medical Cannabis Net Revenue 1 by 22% to... ► Artikel lesen | |
| TILRAY BRANDS | 0,846 | +0,81 % | Neue Regeln für medizinisches Cannabis: Warum Neural Therapeutics in Deutschland mit Hanf.com profitieren könnte | ||
| ORGANIGRAM GLOBAL | 1,280 | -5,88 % | ORGANIGRAM GLOBAL INC. - 6-K, Report of foreign issuer | ||
| SNDL | 1,516 | -1,62 % | SNDL renews share repurchase program | ||
| MYDECINE INNOVATIONS GROUP | 0,150 | 0,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 22.10.2025 | The following instruments on XETRA do have their first trading 22.10.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 22.10.2025
Aktien
1 KYG8827C1006 Malibu Life Holdings... ► Artikel lesen | |
| BIONANO GENOMICS | 1,675 | +4,04 % | Bionano Genomics stock price target lowered to $7 at H.C. Wainwright | ||
| TONIX PHARMACEUTICALS | 12,500 | +0,81 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces FDA IND Clearance for Phase 2 Study of TNX-102 SL for the Treatment of Major Depressive Disorder | Tonix plans to initiate potential pivotal Phase 2 HORIZON study of TNX-102 SL in adults with major depressive disorder in mid-2026 More than 21 million US adults experience a major depressive episode... ► Artikel lesen | |
| HIGH TIDE | 2,210 | +1,14 % | Toronto Stock Exchange, High Tide Inc., The View from the C-Suite | Toronto, Ontario--(Newsfile Corp. - November 14, 2025) - Raj Grover, Chief Executive Officer, High Tide Inc. ("High Tide" or the "Company") (TSXV: HITI), shares the Company's story in an interview... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 3,470 | +0,73 % | Achieve Life Sciences: Raymond James bekräftigt "Strong Buy" mit Kursziel von 20 US-Dollar | ||
| GREENRISE GLOBAL BRANDS | 0,003 | 0,00 % | Greenrise Global Brands Inc: Greenrise files 2024 results, to file Q1 results | ||
| JAGUAR HEALTH | 1,270 | 0,00 % | Jaguar Health, Inc.: Jaguar Health Secures New Patent for Crofelemer in Short Bowel Syndrome, Strengthening Global IP Position Ahead of Additional Clinical Milestones | This new IP supports crofelemer's global exclusivity in rare pediatric intestinal failure coincident with published clinical data showing reductions in parenteral support requirements with crofelemer... ► Artikel lesen | |
| MEDIPHARM LABS | 0,043 | +12,44 % | MediPharm Labs Corp.: MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law | TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,040 | -2,47 % | Argent BioPharma Ltd.: Argent is Growing Through M&A: Projected Merged Company Value of $100M in AC8 Asset Acquisition | Acquisition Expands Clinical Pipeline, Strengthens IP Portfolio, and Grows EU Presence
Highlights
Binding term sheet signed to acquire key assets and IP of AusCann... ► Artikel lesen | |
| AUSCANN | - | - | Argent BioPharma Signs $15m Deal to Acquire Key Clinical and IP Assets from AusCann | ||
| AYR WELLNESS | 0,002 | 0,00 % | Ayr Wellness Inc.: AYR Wellness to Initiate CCAA Proceedings | MIAMI, Nov. 17, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, announces the initiation... ► Artikel lesen |